# Dr Agarwals Eye Hospital Ltd-$ (DRAGARWQ)
> Exchange: NSE | Sector: Pharma | ISIN: INE934C01018

## Price
Current Price: ₹5031.7
Day Change: -2.48%
52W High: ₹5200
52W Low: ₹4600
Market Cap: ₹2,452 Cr

## Valuation
P/E: 34.37
P/B: 7.57
EPS: ₹147.63
Book Value: ₹668.22
Dividend Yield: 0.13%

## Returns
1Y Return: 14.22%

## Profitability
ROE: 26.96%
ROCE: 0%
Debt/Equity: 1.06
Revenue Growth: 22.2%
Profit Growth: 61.6%
EBITDA Margin: 28.69%
Operating Margin: 19.54%

## About
Dr Agarwals Eye Hospital Ltd-$ is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Dr Agarwals Eye Hospital Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026
- Announcement: Receipt Of Order Passed By The Hon'Ble NCLT, In Relation To The Scheme Of Amalgamation Between Dr. Agarwal'S Eye Hospital Limited And Dr. Agarwal'S Health Care Limited
- BSE Filing: Receipt Of Order Passed By The Hon'Ble NCLT, In Relation To The Scheme Of Amalgamation Between Dr. Agarwal'S Eye Hospital Limited And Dr. Agarwal'S Health Care Limited

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-21T20:00:01.518Z
Price History Updated: 2026-05-18T22:58:51.221Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:51.221Z
Quant Updated: 2026-05-18T22:58:51.221Z
Sentiment Updated: 2026-05-18T22:58:51.221Z
Financials Status: current
Financials Updated: 2026-05-18T09:30:01.601Z
Financials Last Attempt: 2026-05-18T09:30:01.601Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹201 Cr
Operating Profit: ₹38 Cr (OPM 19.04%)
Net Profit: ₹24 Cr
Tax: ₹8 Cr

## Annual P&L History
FY 2022: Rev ₹201Cr | PAT ₹24Cr | OPM 19.04%
FY 2023: Rev ₹267Cr | PAT ₹37Cr | OPM 21.17%
FY 2024: Rev ₹317Cr | PAT ₹46Cr | OPM 20.86%

## Balance Sheet (FY 2022)
Total Assets: ₹314 Cr
Total Liabilities: ₹236 Cr
Borrowings: ₹193 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Amar  Agarwal F.R.C.Ophth, F.R.C.S, M.S., MBBS, Founder, Chairman & MD
- Athiya  Agarwal D.O., F.R.S.H(Lon), Founder & Whole Time Director
- Yashwanth  Venkat, Interim Chief Financial Officer
- Meenakshi  Jayaraman, Company Secretary & Compliance Officer
- Adil  Agarwal M.B.B.S, M.S, MBA, CEO & Whole -Time Director

---
Source: rupiya.io/stocks/dragarwq
Disclaimer: For research and education only. Not investment advice.